Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
מצבים רפואיים
Metastatic Digestive System Neuroendocrine Tumor G1 · Metastatic Digestive System Neuroendocrine Tumor G2 · Unresectable Digestive System Neuroendocrine Tumor G1 · Unresectable Digestive System Neuroendocrine Tumor G2
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States
Contact: Principal Investigator (Patrick W. McGarrah)Banner University Medical Center - Tucson, Tucson, Arizona, United States
Contact: Principal Investigator (Rachna T. Shroff)University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States
Contact: Principal Investigator (Rachna T. Shroff)UCHealth University of Colorado Hospital, Aurora, Colorado, United States
Contact: Principal Investigator (Emily Baiyee-Toegel)UM Sylvester Comprehensive Cancer Center at Aventura, Aventura, Florida, United States
Contact: Principal Investigator (Gretel Terrero)UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States
Contact: Principal Investigator (Gretel Terrero)UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States
Contact: Principal Investigator (Gretel Terrero)Mayo Clinic in Florida, Jacksonville, Florida, United States
Contact: Principal Investigator (Patrick W. McGarrah)University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
Contact: Principal Investigator (Gretel Terrero)UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida, United States
Contact: Principal Investigator (Gretel Terrero)University of Miami Sylvester Comprehensive Cancer Center at Sole Mia, North Miami, Florida, United States
Contact: Principal Investigator (Gretel Terrero)UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States
Contact: Principal Investigator (Gretel Terrero)Northwestern University, Chicago, Illinois, United States
Contact: Principal Investigator (Al B. Benson)University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222Contact: Principal Investigator (Chih-Yi Liao)Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States
Contact: Principal Investigator (Al B. Benson)Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States
Contact: Principal Investigator (Al B. Benson)UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States
Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222Contact: Principal Investigator (Chih-Yi Liao)University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States
Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222Contact: Principal Investigator (Chih-Yi Liao)Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States
Contact: Principal Investigator (Al B. Benson)UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, United States
Contact: Principal Investigator (Seema Harichand-Herdt)UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, United States
Contact: Principal Investigator (Seema Harichand-Herdt)Iowa Methodist Medical Center, Des Moines, Iowa, United States
Contact: Principal Investigator (Seema Harichand-Herdt)UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, United States
Contact: Principal Investigator (Seema Harichand-Herdt)UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, United States
Contact: Principal Investigator (Seema Harichand-Herdt)UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, United States
Contact: Principal Investigator (Seema Harichand-Herdt)University of Kentucky/Markey Cancer Center, Lexington, Kentucky, United States
Henry Ford Hospital, Detroit, Michigan, United States
Contact: Principal Investigator (Gazala Khan)Mayo Clinic in Rochester, Rochester, Minnesota, United States
Contact: Principal Investigator (Patrick W. McGarrah)University of New Mexico Cancer Center, Albuquerque, New Mexico, United States
University of Rochester, Rochester, New York, United States
Contact: Principal Investigator (Haoming Qiu)Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Heloisa P. Soares)BCCA-Vancouver Cancer Centre, Vancouver, British Columbia, Canada
Contact: Principal Investigator (Jonathan M. Loree)CancerCare Manitoba, Winnipeg, Manitoba, Canada
Doctor H. Bliss Murphy Cancer Centre, St. John's, Newfoundland and Labrador, Canada
Contact: Principal Investigator (Renee Lester)London Regional Cancer Program, London, Ontario, Canada
Contact: Principal Investigator (David Laidley)Ottawa Hospital and Cancer Center-General Campus, Ottawa, Ontario, Canada
Contact: Principal Investigator (Timothy R. Asmis)Odette Cancer Centre- Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Contact: Principal Investigator (Simron Singh)
מובילי המחקר
Simron Singh
Principal Investigator
Canadian Cancer Trials Group